BIOMARKER FOR ALZHEIMER'S DISEASE OR MILD COGNITIVE IMPAIRMENT

摘要

Desmosterol alone the combination of desmosterol and amyloid beta the combination of desmosterol and gelsolin and the combination of desmosterol amyloid beta and gelsolin can be used as in blood biomarkers for Alzheimer s disease or mild cognitive impairment. Provided are: a method using these biomarkers for evaluating the effect of candidate substances for treatment agents for Alzheimer s disease or mild cognitive impairment; a method for assisting in the diagnosis of Alzheimer s disease or mild cognitive impairment; and a method for diagnosing Alzheimer s disease or mild cognitive impairment.